: The stock trades near $1.16 - $1.20 USD (CGC) or roughly $1.64 CAD (WEED), significantly down from its historical highs but up roughly 2% year-to-date in 2026.
Canopy Growth Corporation () is currently a high-risk, high-reward "penny stock" play that has recently gained momentum due to shifting U.S. cannabis policy and improving internal financials. While the company is showing its narrowest losses to date, significant hurdles like shareholder dilution and intense competition remain. Current Market Performance Canopy Growth Corp (WEED) 1.86% today As of Apr 28, 5:00 AM GMT+9 • Disclaimer Apr 28, 2026 Mkt cap$747.65M CAD 52-wk high3.28 P/E ratio- 52-wk low1.18 Div yield- buy canopy growth corp stock
: Shares have rallied over 30% in the past month as of April 2026, largely driven by the U.S. government's move to reclassify medical marijuana to Schedule III . : The stock trades near $1
: Consensus is currently "Hold" . Average 12-month price targets sit around $1.73 USD , implying a potential 45% upside if regulatory tailwinds continue. The "Buy" Case: Recovery Catalysts While the company is showing its narrowest losses
354